Liping Xie
South China Agricultural University(CN)Ningbo University(CN)Guangdong University of Technology(CN)Soochow University(CN)Zhejiang Cancer Hospital(CN)The Central Hospital of Shaoyang(CN)Hangzhou First People's Hospital(CN)Shanghai Institute of Pharmaceutical Industry(CN)Ningbo First Hospital(CN)First Affiliated Hospital Zhejiang University(CN)Jiangxi Agricultural University(CN)Zhejiang University(CN)
Publications by Year
Research Areas
Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Circular RNAs in diseases
Most-Cited Works
- → The Lancet Commission on prostate cancer: planning for the surge in cases(2024)547 cited
- → YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer(2020)373 cited
- → Prostate cancer in Asia: A collaborative report(2014)208 cited
- → Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels(2017)206 cited
- → Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo(2009)188 cited
- → METTL3/YTHDF2 m 6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer(2020)152 cited